Avadel Pharmaceuticals Plc

Ownership Transactions Reported by 12 Insiders

Symbol
AVDL on Nasdaq
Industry
Pharmaceutical Preparations
Location
Block 10 1 Blanchardstown Corporate Park, Ballycoolin, Dublin, Ireland

Insiders trading volume in the past year

Avadel Pharmaceuticals Plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Eric J. Ende Director $2.08M +$235K +12.7% Jul 29, 2025
Gregory J. Divis Chief Executive Officer, Director $1.75M +$99.7K +6.03% Mar 5, 2025
Peter J. Thornton Director $1.09M +$80.5K +7.97% Jul 29, 2025
Geoffrey Michael Glass Director $1.03M +$200K +24% Sep 15, 2025
Linda Palczuk Director $851K +$70.2K +8.99% Sep 15, 2025
Mark Anthony McCamish Director $843K Jul 29, 2025
Thomas S. Mchugh Chief Financial Officer $796K +$76.5K +10.6% Mar 5, 2025
Naseem Amin Director $208K Jul 29, 2025
Jerad G. Seurer Gen. Counsel & Corp. Secretary $186K Mar 5, 2025
Douglas J. Williamson Chief Medical Officer Feb 14, 2022
Richard J. Kim Chief Commercial Officer Feb 20, 2024
Susan Rodriguez Chief Operating Officer May 13, 2025

Recent Insider Transactions by Companies or Individuals for Avadel Pharmaceuticals Plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.